bay h 4502 has been researched along with bay n 7133 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cauwenbergh, G | 1 |
| Abbott, AB; Odds, FC; Webster, CE | 1 |
| Espinel-Ingroff, A; Kerkering, TM; Shadomy, S | 1 |
| Heins, J; Heins, S; Rumler, W | 1 |
4 other study(ies) available for bay h 4502 and bay n 7133
| Article | Year |
|---|---|
New and prospective developments in antifungal drugs.
Topics: Administration, Oral; Administration, Topical; Allylamine; Antifungal Agents; Clotrimazole; Dermatomycoses; Drug Compounding; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Terbinafine; Triazoles | 1986 |
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
Topics: Antifungal Agents; Aspergillus; Candida; Clotrimazole; Econazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Morpholines; Triazoles | 1984 |
In-vitro studies with four new antifungal agents: BAY n 7133, bifonazole (BAY h 4502), ICI 153,066 and Ro 14-4767/002.
Topics: Antifungal Agents; Arthrodermataceae; Blastomyces; Candida; Coccidioides; Cryptococcus neoformans; Drug Evaluation, Preclinical; Histoplasma; Imidazoles; Ketoconazole; Miconazole; Morpholines; Sporothrix; Triazoles | 1984 |
[Relation between the antibiotic concentration and contact time of the effect of 5-fluorocytosine, bifonazole and Bay N 7133 on Candida albicans].
Topics: Antifungal Agents; Candida albicans; Cytosine; Flucytosine; Imidazoles; Microbial Sensitivity Tests; Solutions; Time Factors; Triazoles | 1984 |